Skip to main content
Signal8

Imagion Biosystems Limited (IBXXF)

Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nanotechnology, biotechnology, and cancer diagnostics, all built upon its proprietary superparamagnetic relaxometry platform. Imagion's product pipeline includes MagSense, which is currently undergoing Phase I clinical trials for its application in HER2-positive breast cancer detection and management, as well as PrecisionMRX, an iron oxide nanoparticle engineered for general cancer detection. Imagion Biosystems also fosters strategic alliances, including a collaborative research program with Patrys Limited designed to integrate their respective technologies for improved imaging and diagnosis of brain tumors. Additionally, the company has a joint development agreement with Global Cancer Technology, Inc. to further develop GCT's novel nanoscintillator technology for the therapeutic treatment of breast cancer. The company was founded in 2016 and is headquartered in San Diego, California.

Sector: Medical - Diagnostics & Research

Industry: Medical - Diagnostics & Research

Imagion Biosystems Limited logo

Imagion Biosystems Limited

OTC:IBXXFHealthcare
CLOSED
Mkt Cap-
EV-
Float220.68M
O/S539.94M
VOL750 sh
$ Vol$3
Inst Own-
Net Cash/Sh-
Dilution
Short interest (FINRA)
Not computed yet: no FINRA short interest has been matched to this float.

Float 220.68M · FMP free float

375
Sep 15 (1159d)
3.78
Sep 15 (1159d)
Borrow (IBKR)

The cost to borrow IBXXF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver

No price or settlement history available to chart.

Off-exchange short volume

Too few published sessions to show a reading in context.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for IBXXF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually